Newtyn Management’s Fractyl Health GUTS Stock Holding History

Newtyn Management’s Portfolio GUTS Stock Details GUTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,134,021	Closed	-$2.49M	–	39
2025 Q4	$2.49M	Buy	+1,134,021	New	+$1.83M	0.26%	31

Other funds holding GUTS

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Newtyn Management's GUTS Position: Q1 2026 in Review

Newtyn Management sold out of Fractyl Health (GUTS) in Q1 2026, closing a stake of 1,134,021 shares — an estimated $2.49M sold.

Newtyn Management first reported a position in GUTS in Q4 2025 and held it in 1 quarter. The position peaked at $2.49M in Q4 2025. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

Newtyn Management reported no remaining Fractyl Health position as of Q1 2026 after selling out during the quarter.
Newtyn Management sold 1,134,021 Fractyl Health shares in Q1 2026, an estimated $2.49M.
Newtyn Management first reported a position in Fractyl Health in Q4 2025 and held it in 1 quarter.
Newtyn Management's Fractyl Health position peaked at $2.49M in Q4 2025.
83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on Newtyn Management's 13F filing for Q1 2026, filed 15 May 2026.